Long Term Treatment of Multiple Sclerosis with Interferon- May Be Cost Effective

Author： Kendrick M.   Johnson K.I.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.18, Iss.1, 2000-07, pp. : 45-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Cost Effectiveness of Interferon- -1a in the Treatment of Relapsing-Remitting Multiple Sclerosis: An Econometric Model

By Lepen C.  

Clinical Drug Investigation, Vol. 23, Iss. 9, 2003-01 ,pp. : 571-581

Adis International

Access to resources Recommend Favorite

IFN- -1a cost effective long term for multiple sclerosis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 428, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

IFN- -1a cost effective long term for multiple sclerosis

By  

Inpharma, Vol. 1, Iss. 1403, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Disease-Modifying Agents in the Treatment of Multiple Sclerosis: A Review of Long-Term Outcomes

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 6, 2009-12 ,pp. : 512-519

Bentham Science Publishers

Access to resources Recommend Favorite

Interferon-β1b for the treatment of multiple sclerosis

By Lam Sum   Wang Shan   Gottesman Malcolm  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1111-1117

Informa Healthcare

Access to resources Recommend Favorite